Evidence map›Paper›PMID 35784302›Full record

ArticleFrontiers in immunology2022

Immunological Effects of Recombinant

Jinhui Sun, Mengmeng Zhang, Dandan Zhao, Jiawei Yang, Yanxue Shi, Baoxing Xu, Xuefei Liu, Xueting Guan, Wen Shi, Min Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jinhui SunCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Mengmeng ZhangCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Dandan ZhaoCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Jiawei YangCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Yanxue ShiCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Baoxing XuCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Xuefei LiuCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Xueting GuanCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Wen ShiCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Min LiuCollege of animal Science and Technology, Northeast Agicultural University, Harbin, China.
Northeast Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IHNV is a virus that infects salmonids and causes serious economic damage to the salmonid farming industry. There is no specific treatment for the disease caused by this pathogen and the main preventive measure is vaccination, but this is only possible for small groups of individuals. Therefore, it is important to investigate new oral vaccines to prevent IHNV. In this study, the CK6 chemokine protein of rainbow trout and the truncated G protein of IHNV were used to construct a secretory expression recombinant

Indexed as

Fish DiseasesInfectious hematopoietic necrosis virusLacticaseibacillus caseiOncorhynchus mykissRhabdoviridae InfectionsViral VaccinesAdministration, OralAnimalsChemokinesGTP-Binding ProteinsVaccinesChemokinesGTP-Binding ProteinsVaccinesViral VaccinesCK6G proteinIHNVLactobacillus caseioral vaccines

Identifiers

PMID35784302
PMCPMC9245430
OpenAlexW4283028075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.